Attovia Therapeutics updates charter after IPO
Attovia Therapeutics, Inc. implemented an Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws on August 6, 2026, in connection with the closing of its initial public offering of common stock, par value $0.0001 per share.
Rhea-AI Filing Summary
Attovia Therapeutics, Inc. implemented an Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws on August 6, 2026, in connection with the closing of its initial public offering of common stock, par value $0.0001 per share. The board of directors and stockholders had previously approved these revised governing documents to become effective immediately prior to the offering’s closing, as described in the company’s final prospectus dated August 4, 2026. The company’s common stock trades under the symbol ATTO on the Nasdaq Global Market.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 5.03, 9.01
2 items
Item 5.03
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Charter and bylaws effective date: August 6, 2026
Par value per share: $0.0001 per share
Trading symbol: ATTO
3 metrics
Charter and bylaws effective date
August 6, 2026
Date amended and restated charter and bylaws became effective with IPO closing
Par value per share
$0.0001 per share
Par value of Attovia Therapeutics common stock
Trading symbol
ATTO
Ticker for common stock on the Nasdaq Global Market
Key Terms
Amended and Restated Certificate of Incorporation, Amended and Restated Bylaws, initial public offering, Description of Capital Stock
4 terms
Amended and Restated Certificate of Incorporation regulatory
"filed its Amended and Restated Certificate of Incorporation (the “Charter”)"
A company’s amended and restated certificate of incorporation is an updated version of its foundational legal charter that replaces the older document and folds in all changes into one clear copy; it spells out corporate structure, classes of stock, shareholder rights and key governance rules. Investors care because it can change who controls the company, how votes are counted, what claims shareholders have on assets or dividends, and can introduce or remove protections against takeovers—like updating a house title after a major renovation to show who owns what and under what rules.
Amended and Restated Bylaws regulatory
"its Amended and Restated Bylaws (the “Bylaws”) became effective"
A company’s amended and restated bylaws are its internal rulebook rewritten to include all changes in one updated document, replacing the old bylaws. For investors, this matters because the bylaws set how the board, shareholders and officers make decisions, hold votes and handle disputes; a new consolidated version can change voting rights, control mechanisms or procedures that affect corporate governance and the value or risk of an investment.
initial public offering financial
"in connection with the closing of the initial public offering"
An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.
Description of Capital Stock financial
"set forth in the section titled “Description of Capital Stock” in the Prospectus"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What corporate changes did Attovia Therapeutics (ATTO) implement on August 6, 2026?
Attovia Therapeutics implemented an Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws on August 6, 2026, timed to become effective immediately prior to the closing of its initial public offering of common stock.
How are Attovia Therapeutics’ (ATTO) new charter and bylaws linked to its IPO?
The updated charter and bylaws were approved by the board and stockholders to be effective immediately prior to the IPO closing, aligning the company’s corporate governance framework with its status as a newly public company following the initial public offering.
Where can investors find details of Attovia Therapeutics’ (ATTO) charter and bylaws provisions?
Key provisions of the charter and bylaws are described in the “Description of Capital Stock” section of Attovia Therapeutics’ final prospectus dated August 4, 2026, which accompanied its registration statement for the initial public offering.
What is the par value and exchange listing for Attovia Therapeutics (ATTO) common stock?
Attovia Therapeutics’ common stock has a par value of $0.0001 per share and is listed for trading on the Nasdaq Global Market under the ticker symbol ATTO, as identified in the company’s disclosure.
Who signed the corporate governance update for Attovia Therapeutics (ATTO)?
The report documenting the charter and bylaws changes was signed on behalf of Attovia Therapeutics by Steven Chan, the company’s Chief Financial Officer, dated August 6, 2026, confirming the company’s authorization of the disclosed governance actions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
